Waypoint Bio Competitors and Similar CompaniesClear all
Waypoint Bio's competitors and similar companies include Anokion, Fulcrum Therapeutics and Genevant.
 Waypoint Bio Waypoint Bio is a biotech company that develops cell therapies for solid tumors and autoimmune diseases. |  Fulcrum Therapeutics We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are. |  Genevant Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics. | ||
Founding Date | Founding Date 2021 | Founding Date 2010 | Founding Date 2016 | Founding Date 2017 |
Type | Type Private | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations New York, US HQ New York, US | Locations Ecublens, CH HQ Cambridge, US | Locations Cambridge, US HQ | Locations New York, US HQ |
Employees | Employees 157% increase | Employees 219% decrease | Employees 43223% increase | Employees 524% decrease |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 77.6m | Total funding raised $ 55m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Anokion
HQ
Ecublens, CH
Employees
21↓ 9% decrease
Anokion is an immune tolerance company focused on autoimmune disease treatment.
View companyFulcrum Therapeutics
HQ
Cambridge, US
Employees
432↑ 23% increase
We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.
View companyGenevant
HQ
New York, US
Employees
52↓ 4% decrease
Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics.
View company